Track: COVID-19 Impact on Cancer

COVID-19 Impact on Cancer

Delays in Cancer Diagnosis and Screening
The COVID-19 pandemic led to a significant reduction in cancer screenings, resulting in delayed diagnoses. This delay can lead to later-stage cancer identification, reducing the chances of successful treatment.

Disruptions in Cancer Treatment
Many cancer treatments, including surgeries and chemotherapy, were delayed or rescheduled due to the pandemic. This disruption has impacted patient outcomes and may affect the long-term survival rates for some cancer types.

Impact on Cancer Patient Care and Well-being
The pandemic has caused significant psychological stress for cancer patients due to fears of exposure to COVID-19 and disruptions in care. Mental health support became a critical aspect of managing cancer during the crisis.

Shift to Telemedicine and Remote Care
To mitigate risks, many cancer consultations and follow-ups moved to virtual platforms. Telemedicine became a vital tool for ongoing cancer care, providing patients with access to medical professionals while reducing exposure to the virus.

Post-Pandemic Recovery in Cancer Care
As healthcare systems recover, there is a need for strategies to catch up on missed screenings, treatments, and follow-ups. This point will focus on how healthcare providers are adapting to ensure that cancer care is not further delayed and patients receive timely attention.